Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FWFDB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,250
Award facts
- Contract value 100% obligated
- $13,250.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $13,250.30 to DMS Pharmaceutical Group Inc. for NUCALA 100 mg/ml auto-injector units on September 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a pharmaceutical supply to support Department of Defense healthcare operations. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business. The ordering is being fulfilled from Park Ridge, Illinois, where the company maintains its primary operations.
This delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million through November 2026. The parent contract enables the agency to procure a broad range of pharmaceutical products, including branded and generic prescription medications, biologics, and specialized medical consumables for military health facilities worldwide. NUCALA, a monoclonal antibody used in respiratory and immunological treatments, represents the type of specialized pharmaceutical product within DMS Pharmaceutical Group's extensive portfolio supporting federal military healthcare supply chains.
Quick answers
Who was awarded contract SPE2DB25FWFDB?
SPE2DB25FWFDB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FWFDB worth?
The government has obligated $13,250 on SPE2DB25FWFDB.
Is contract SPE2DB25FWFDB an order under another contract?
Yes. SPE2DB25FWFDB is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFDB competed?
The extent of competition for SPE2DB25FWFDB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award